WILLIAM SCHWIETERMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2008-10-30 William Schwieterman(10) Includes 30,000 shares of unvested restricted common stock granted in 2007, which vest in equal annual installments over a four-year period, all of which are subject to transfer and forfeiture restrictions.
2010-11-12 William Schwieterman(7) Includes 10,000 shares of unvested restricted common stock granted in 2007, which vest in equal annual installments over a four-year period, all of which are subject to transfer and forfeiture restrictions.
2011-02-18 William Schwieterman(6) Includes 10,000 shares of unvested restricted common stock granted in 2007, which vest in equal annual installments over a four-year period, all of which are subject to transfer and forfeiture restrictions.
2012-11-19 William Schwieterman(6) 105,060 * (6) Includes options to purchase 96,100 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.

Data sourced from SEC filings. Last updated: 2025-10-11